tiprankstipranks
Advertisement
Advertisement

EDIT Stock Latest News

Phil Nadeau Reiterates Buy on Editas Medicine, Citing Strong Cash Runway and Upcoming EDIT-401 Clinical Catalyst
RatingsPhil Nadeau Reiterates Buy on Editas Medicine, Citing Strong Cash Runway and Upcoming EDIT-401 Clinical Catalyst
4d ago
EDIT
Editas Medicine Strengthens Board With New Cardiology Director
PremiumCompany Announcements
Editas Medicine Strengthens Board With New Cardiology Director
4d ago
8K
EDIT
Editas Medicine reports Q2 EPS (15c), consensus (28c)
PremiumThe Fly
Editas Medicine reports Q2 EPS (15c), consensus (28c)
4d ago
EDIT
EDIT Earnings this Week: How Will it Perform?
PremiumPre-Earnings
EDIT Earnings this Week: How Will it Perform?
7d ago
EDIT
Editas Medicine Shareholders Back Board, Pay and Auditor
PremiumCompany Announcements
Editas Medicine Shareholders Back Board, Pay and Auditor
2M ago
8K
EDIT
Private Markets: Bezos’ Prometheus raises $12B as OpenAI files for IPO
PremiumThe FlyPrivate Markets: Bezos’ Prometheus raises $12B as OpenAI files for IPO
2M ago
GS
TP
Editas Medicine preclinical data ‘looks highly supportive,’ says Evercore ISI
Premium
The Fly
Editas Medicine preclinical data ‘looks highly supportive,’ says Evercore ISI
2M ago
EDIT
TD Cowen remains bullish on Editas Medicine after ‘compelling preclinical data’
Premium
The Fly
TD Cowen remains bullish on Editas Medicine after ‘compelling preclinical data’
2M ago
EDIT
Editas Medicine Raises Capital Through Public Equity Offering
PremiumCompany Announcements
Editas Medicine Raises Capital Through Public Equity Offering
3M ago
8K
EDIT
Editas Medicine 55.6M share Secondary priced at $2.25
PremiumThe Fly
Editas Medicine 55.6M share Secondary priced at $2.25
3M ago
EDIT
Editas Medicine Suspends Existing At-The-Market Offering Prospectus
PremiumCompany Announcements
Editas Medicine Suspends Existing At-The-Market Offering Prospectus
3M ago
8K
EDIT
Editas Medicine announces common stock, warrant offering, no amount given
PremiumThe Fly
Editas Medicine announces common stock, warrant offering, no amount given
3M ago
EDIT
Editas Showcases Promising EDIT-401 Data for Hyperlipidemia
PremiumCompany AnnouncementsEditas Showcases Promising EDIT-401 Data for Hyperlipidemia
3M ago
8K
EDIT
Analyst Maintains Buy on Editas Medicine, Reiterates $5 Price Target on EDIT-401 Progress and Strong Cash Runway
Premium
Ratings
Analyst Maintains Buy on Editas Medicine, Reiterates $5 Price Target on EDIT-401 Progress and Strong Cash Runway
3M ago
EDIT
Editas Medicine presented preclinical data for EDIT-401 at EAS Congress
Premium
The Fly
Editas Medicine presented preclinical data for EDIT-401 at EAS Congress
3M ago
EDIT
Editas Showcases Promising EDIT-401 Hyperlipidemia Preclinical Data
PremiumCompany Announcements
Editas Showcases Promising EDIT-401 Hyperlipidemia Preclinical Data
3M ago
8K
EDIT
Editas Medicine’s EDIT-401 shows efficacy and safety in hyperlipidemia
PremiumThe Fly
Editas Medicine’s EDIT-401 shows efficacy and safety in hyperlipidemia
3M ago
EDIT
FDA Commissioner Marty Makary resigns
PremiumThe Fly
FDA Commissioner Marty Makary resigns
3M ago
AZN
BMY
Analyst Phil Nadeau Reiterates Buy on Editas Medicine, Citing Promising EDIT-401 Data, Strong Cash Runway, and Large Untapped HeFH Opportunity
PremiumRatings
Analyst Phil Nadeau Reiterates Buy on Editas Medicine, Citing Promising EDIT-401 Data, Strong Cash Runway, and Large Untapped HeFH Opportunity
3M ago
EDIT
Editas Medicine reports Q1 EPS (26c), consensus (24c)
PremiumThe FlyEditas Medicine reports Q1 EPS (26c), consensus (24c)
3M ago
EDIT
EDIT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
EDIT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
EDIT
Private Markets: Cursor in talks for $2B, Blue Energy secures $380M
Premium
The Fly
Private Markets: Cursor in talks for $2B, Blue Energy secures $380M
4M ago
BA
BE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >